IP LAW PLATFORM
propriété intellectuelle
intellectual property
contributeurs
contributors
concours
contest
bulletins
reviews
s'inscrire
join us
Chercher/Search
connexion
log in 
 déconnexion
log out
à propos
about
conditions
terms of use
plan
sitemap
contact
contact
admin
admin
>CONTRIBUTEURS
contributors
Liste des contributeurs
List of contributors
Devenir contributeur
Become contributor
Accueil contributeur
Contributor Home





retour / back


Billion Dollar Lawsuit against Glaxo over Cancer Drug




By Sébastien ODDOS member of a.d.c.i. - Date : 2010-03-26 - Country : ETATS-UNIS - Subject : Litigations - IP Field : Industrial Property


Reuters report a multi billion dollar drug patent lawsuit between Biogen / Genentech and GlaxoSmithKline.
U.K. Pharma group GlaxoSmithKline (the second largest pharmaceutical company) and Danish biotech company Genmab A/S have jointly developed the following cancer drugs:

- Arzerra, approved last October by the U.S. FDA (Food and Drug Administration) for treating chronic lymphocytic leukemia patients who fail to respond to other therapies. Arzera’s US fourth-quarter sales were about $5.2 million and received conditional EU approval at the beginning of 2010.

- Rituxan ($5.7 billion in 2009) which was first approved thirteen years ago to treat non-Hodgkin's [...]

En savoir plus ? Pour cela, créer GRATUITEMENT votre compte. Dans une seconde, vous pourrez poursuivre votre lecture.
Learn more? If so, create your FREE account. It will take you a second before going back to this paper.



OUVRIR MON COMPTE
CREATE MY ACCOUNT